Health-related quality of life after direct endovascular thrombectomy and bridging therapy: findings of DIRECT-MT trial - Summary - MDSpire

Health-related quality of life after direct endovascular thrombectomy and bridging therapy: findings of DIRECT-MT trial

  • By

  • Renjun Gu

  • Meihua Huyan

  • Hongjian Zhang

  • Fang Shen

  • Hongjian Shen

  • Zifu Li

  • Pengfei Xing

  • Weilong Hua

  • Yongxin Zhang

  • Jianmin Liu

  • Pengfei Yang

  • Lei Zhang

  • Yongwei Zhang

  • May 25, 2026

  • 0 min

Share

Objective:

To compare health-related quality of life (HRQoL) outcomes between endovascular thrombectomy (EVT) alone and bridging therapy in patients with large-vessel occlusion stroke, and to assess the effect of baseline severity on these outcomes.

Key Findings:
  • Overall HRQoL at 90 days was similar between EVT alone (median EQ-5D 0.84) and bridging therapy (median EQ-5D 0.85).
  • Baseline stroke severity modified the treatment-EQ-5D association, with bridging therapy associated with higher EQ-5D in moderate-to-severe stroke (NIHSS 16–20) and severe stroke (NIHSS 21–42).
  • Exploratory analyses indicated bridging therapy favored patients with near-complete independence (BI 91–100), while EVT alone was associated with lower EQ-5D in those with favorable functional outcomes (mRS 0–2).
  • EVT alone showed lower odds of symptom-free Mobility and Usual activities in near-independent patients, and a treatment-by-baseline severity interaction was noted for Anxiety/depression.
Interpretation:

HRQoL at 90 days was comparable overall between treatment strategies, but varied by baseline stroke severity and functional outcomes, as indicated by the study findings.

Limitations:
  • The study is a secondary analysis and may not capture all relevant patient-centered outcomes.
  • Exploratory analyses may introduce biases.
Conclusion:

The findings indicate that treatment effects on HRQoL differ by baseline stroke severity.

Original Source(s)

Related Content